In particular, during tumour development, immune response is activated by the binding of T-cell receptor (TCR), expressed by T cells, and tumour associated antigens (TAA) within MHC molecules, via the activity of antigen-presenting cells (APCs), such as dendritic cells. Here, HLA-C is linked to neoplasm.